MENU
MBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MBX Biosciences (MBX) Ownership - Who owns MBX Biosciences?
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
479.38M
P/E Ratio
N/A
Total Cash
224.91M
Projected Growth
N/A
Total Debt
650K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.69
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MBX
Capitalization
479M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
225M
Total Cash/Share
6.69
Total Debt
650K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
219M
P/B Ratio
2.19
Cash Flow
N/A
Earnings
-6.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
19.50
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-86.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-52.32
Shares Held By Institutions
300M
Shares Outstanding - Current
33.6M
Total Liabilities
12.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-22.572
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information